TrialsgrambetaRCTs are beautiful

European Resuscitation Council Guidelines 2025

This guideline cites 20 of the 61 landmark trials in our Emergency medicine register.

The ERC Guidelines 2025, launched in Rotterdam on 22 October 2025, replace the 2021 edition and run to twelve chapters — epidemiology, systems saving lives, adult basic and advanced life support, special circumstances, post-resuscitation care, newborn and paediatric life support, ethics, education and first aid. They are built on the ILCOR consensus on science and shift several long-standing positions: targeted temperature management gives way to temperature control with active fever prevention, extracorporeal CPR is formalised as a rescue option in selected patients and systems, and the adult ALS chapter reworks defibrillation strategy, airway management and the route of drug delivery. This page groups the landmark trials from our register that underpin those chapters by theme, so a recommendation can be traced back to the randomised evidence behind it.

Basic life support & defibrillation2

  • 2022DOSE-VF⁠ICU · Post-arrest · DefibrillationIn 405 patients with refractory ventricular fibrillation, double sequential external defibrillation improved survival to hospital discharge versus standard defibrillation.RR 2.2195% CI 1.33-3.67Read →
  • 2015PARAMEDIC (LUCAS-2)⁠Emergency · CPR · Mechanical CPRIn 4,471 out-of-hospital cardiac arrests, LUCAS-2 mechanical chest compression did not improve 30-day survival versus manual CPR, and worsened functional outcome at 3 months.OR 0.8695% CI 0.64-1.15Read →

Advanced life support: drugs during CPR2

  • 2018PARAMEDIC2 Core⁠ICU · Post-arrest · AdrenalineIn 8,014 adults with OHCA, 1 mg intravenous adrenaline increased 30-day survival versus placebo, without improving favourable neurologic survival.OR 1.39Read →
  • 2016ALPS⁠Emergency · CPR · AntiarrhythmicsIn 3,026 adults with OHCA and shock-refractory VF/pVT, amiodarone or lidocaine did not improve survival to hospital discharge versus placebo.Read →

Airway management3

  • 2023DEVICE⁠Emergency · Airway · Video laryngoscopyIn 1,417 critically ill adults in EDs and ICUs, video laryngoscopy improved first-pass intubation success versus direct laryngoscopy.85.1% vs 70.8%Read →
  • 2019PreVent 2019⁠Emergency · Airway · Bag-mask ventilationIn 401 critically ill adults undergoing tracheal intubation, bag-mask ventilation between induction and laryngoscopy reduced severe hypoxaemia versus no ventilation.96% vs 93%Read →
  • 2018AIRWAYS-2⁠Emergency · Airway · Supraglottic vs ETIIn 9,296 adults with out-of-hospital cardiac arrest, an i-gel supraglottic airway did not change favourable neurologic outcome at discharge versus endotracheal intubation.6.4% vs 6.8%Read →

Extracorporeal CPR (eCPR)3

  • 2023INCEPTION⁠ICU · Post-arrest · ECPRIn 160 patients with refractory OHCA, ECPR did not improve 30-day survival with favourable neurology versus conventional CPR.OR 1.495% CI 0.5-3.5Read →
  • 2022PRAGUE-OHCA⁠Emergency · ECPR · ECPRIn 256 patients with refractory out-of-hospital cardiac arrest, a hyperinvasive strategy (intra-arrest transport + ECPR + immediate cath) did not significantly improve 180-day CPC 1–2 survival versus standard ACLS.OR 1.6395% CI 0.93-2.85Read →
  • 2020ARREST 2020⁠ICU · Post-arrest · ECPRIn 30 patients with refractory out-of-hospital VF arrest, ECPR plus expedited coronary angiography improved survival to hospital discharge versus standard ACLS.43% vs 7%Read →

Post-resuscitation care: temperature control3

  • 2021TTM2 Core⁠Cardiology · Critical care · Temperature managementIn 1,861 unconscious adults after OHCA, hypothermia at 33 °C did not reduce all-cause mortality at 6 months compared with targeted normothermia (≤ 37.5 °C).RR 1.04Read →
  • 2019HYPERION⁠Cardiology · Critical care · Temperature managementIn 581 patients resuscitated from cardiac arrest with a non-shockable rhythm, targeted hypothermia at 33 °C improved favourable neurological outcome compared with targeted normothermia.10.2% vs 5.7%Read →
  • 2013TTM⁠Cardiology · Critical care · Temperature managementIn 939 unconscious survivors of out-of-hospital cardiac arrest, targeted temperature of 33 °C did not improve survival or neurological outcome compared with 36 °C.HR 1.06Read →

Post-resuscitation care: haemodynamic & oxygen targets2

  • 2022BOX (BP)⁠ICU · Post-arrest · Haemodynamic targetsIn 789 comatose survivors of OHCA, a higher MAP target (77 mm Hg) did not change the composite of death or severe disability versus a lower target (63 mm Hg).HR 1.0895% CI 0.84-1.37Read →
  • 2022BOX (O₂)⁠ICU · Post-arrest · Oxygen targetsIn 789 comatose survivors of OHCA, restrictive oxygenation (PaO₂ 68–75 mm Hg) did not change the composite of death or severe disability compared with liberal (98–105 mm Hg).HR 0.95Read →

Coronary angiography after cardiac arrest2

  • 2021TOMAHAWK⁠Emergency · Post-arrest · Immediate angiographyIn 554 OHCA patients without ST-elevation, immediate angiography did not improve 30-day all-cause mortality versus delayed/selective strategy.HR 1.2895% CI 1.00-1.63Read →
  • 2019COACT⁠Emergency · Post-arrest · Immediate angiographyIn 552 OHCA survivors with a shockable rhythm and no STEMI, immediate coronary angiography did not improve 90-day survival versus delayed angiography.OR 0.8995% CI 0.62-1.27Read →

Special circumstances: traumatic cardiac arrest3

  • 2018PAMPer⁠Emergency · Trauma · Prehospital plasmaIn 501 trauma patients at risk of haemorrhagic shock during HEMS transport, 2 units of prehospital thawed plasma reduced 30-day mortality versus standard care.23.2% vs 33.0%Read →
  • 2015PROPPR⁠ICU · Transfusion · Trauma resuscitationIn 680 patients with severe trauma haemorrhage, a 1:1:1 plasma:platelet:RBC ratio did not change 24-hour or 30-day mortality versus 1:1:2, but reduced death from exsanguination at 24 hours.Read →
  • 2010CRASH-2 Core⁠ICU · Transfusion · Tranexamic acidIn 20,211 trauma patients with significant haemorrhage, tranexamic acid within 3 hours reduced all-cause death versus placebo.RR 0.91Read →

Cited landmark trials not yet in the register6

Further landmark trials this guideline cites that are not (yet) covered in our register. Each links out to the study for further reading.

  • 2023TAME

    Targeted mild hypercapnia versus normocapnia after out-of-hospital cardiac arrest — no benefit on neurological outcome.

  • 2025PARAMEDIC-3

    Intraosseous-first versus intravenous-first drug route in out-of-hospital cardiac arrest — no survival difference.

  • 2025IVIO

    Danish counterpart to PARAMEDIC-3; intraosseous access did not improve sustained ROSC or survival.

  • 2018PART

    Laryngeal tube versus endotracheal intubation as the initial airway strategy during out-of-hospital CPR.

  • 2021COCA

    Calcium during advanced life support for out-of-hospital cardiac arrest — stopped early for harm signal.

  • 2021VAM-IHCA

    Vasopressin plus methylprednisolone during in-hospital cardiac arrest — more ROSC, no survival benefit.

Every trial shown is one this guideline actually cites: each link was checked against the guideline's own reference list, and the few that a machine cannot match, a trial cited through a later follow-up, or a NICE guideline, which carries no DOI, were verified by hand against the full text. This is not the guideline's complete reference list, only the landmark trials it cites that our register holds.